OOIR: Observatory of International Research

Papers

(The H4-Index of Movement Disorders is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy	316
Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression	125
Rapid Onset Functional Tic‐Like Behaviors in Young Females During the COVID‐19 Pandemic	95
Guidelines for Speech Recording and Acoustic Analyses in Dysarthrias of Movement Disorders	94
Neuroimaging of Anxiety in Parkinson's Disease: A Systematic Review	89
Genotype–Phenotype Relations for Isolated Dystonia Genes: MDSGene Systematic Review	87
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease	86
GP2: The Global Parkinson's Genetics Program	84
Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation	81
European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies	78
Validation of α‐Synuclein in L1CAM‐Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian Syndromes	77
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals	73
Prevalence and Incidence of Huntington's Disease: An Updated Systematic Review and Meta‐Analysis	72
The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease	70
Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource	67
RT‐QuIC Detection of Pathological α‐Synuclein in Skin Punches of Patients with Lewy Body Disease	67
International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease	66
A Novel SNCA A30G Mutation Causes Familial Parkinsonʼs Disease	66
Bilateral Focused Ultrasound Thalamotomy for Essential Tremor (BEST‐FUS Phase 2 Trial)	65
Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related Disorders	64
α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease	64
Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms	62
The Rostock International Parkinson's Disease (ROPAD) Study: Protocol and Initial Findings	62
GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based Study	61
Prevalence of Parkinson's Disease: A Community‐Based Study in China	60

Closed‐Loop Deep Brain Stimulation for Essential Tremor Based on Thalamic Local Field Potentials	60
Pandemic Tic‐like Behaviors Following Social Media Consumption	59
Global and Regional Changes in Perivascular Space in Idiopathic and Familial Parkinson's Disease	58
Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force – An Update	58
Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker	58
Parkinson's Disease and Post–COVID‐19 Syndrome: The Parkinson's Long‐COVID Spectrum	56
MIND and Mediterranean Diets Associated with Later Onset of Parkinson's Disease	55
Cortical [¹⁸F]PI‐2620 Binding Differentiates Corticobasal Syndrome Subtypes	55
Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease	53
Clinical Utility of ¹⁸F‐APN‐1607 Tau PET Imaging in Patients with Progressive Supranuclear Palsy	50
Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease	50
Reduced Synaptic Density in Patients with Lewy Body Dementia: An [¹¹C]UCB‐J PET Imaging Study	49
Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed‐Start Analysis of the MOXIe Extension	49
Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning	48
Risk of Hospitalization and Death for COVID‐19 in People with Parkinson's Disease or Parkinsonism	48
Diagnostic Value of Salivary Real‐Time Quaking‐Induced Conversion in Parkinson's Disease and Multiple System Atrophy	48
Air Pollution and the Risk of Parkinson's Disease: A Review	47
Dopamine Receptors in Parkinson's Disease: A Meta‐Analysis of Imaging Studies	47
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PD_GBA	47
Development and Validation of a Patient‐Reported Outcome Measure of Ataxia	46
Cognitive Determinants of Dysarthria in Parkinson's Disease: An Automated Machine Learning Approach	46